Library

Protocol

Semaglutide (20mg Vial)

Complete dosage protocol and reconstitution guide for Semaglutide (20mg Vial).

Updated November 26, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismSemaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control. The extended half-life enables once-weekly subcutaneous dosing, which is the standard clinical approach [1] .
DosingReference dose shown on this page: See guide.
ReconstitutionAdd 3.0 mL diluent to a 20 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 28 days.

Calculator preset

Run the vial math before tracking.

At ~6.67 mg/mL, 1 mg = 0.15 mL = 15 units on a U-100 insulin syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control. The extended half-life enables once-weekly subcutaneous dosing, which is the standard clinical approach [1] . This educational protocol presents a gradual weekly titration from 0.25 mg up to a maintenance dose of 2.4 mg over 16+ weeks, using a practical dilution for precise insulin-syringe measurements.

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 6.67 mg/mL concentration. Weekly
Reference doseReference dose shown on this page: See guide.
Easy measuringAt ~6.67 mg/mL, 1 mg = 0.15 mL = 15 units on a U-100 insulin syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 28 days.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Titration (3 mL = ~6.67 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–4250 mcg (0.25 mg)4 units (0.04 mL)
Weeks 5–8500 mcg (0.5 mg)7.5 units (0.075 mL)
Weeks 9–121000 mcg (1.0 mg)15 units (0.15 mL)
Weeks 13–161700 mcg (1.7 mg)25.5 units (0.255 mL)
Weeks 17+(Maintenance) 2400 mcg (2.4 mg)36 units (0.36 mL)

Reference dose shown on this page: See guide.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to minimize foaming; avoid shaking.
  3. Gently swirl or roll the vial until the powder is fully dissolved.
  4. Label the vial with the reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
  5. Use reconstituted solution within 28 days for maximum potency and safety [8] .

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks ≈ 1 vial (3 mg total used)
  • 12 weeks ≈ 1 vial (7 mg total used)
  • 16 weeks ≈ 1 vial (13.8 mg total used)
  • 20 weeks ≈ 2 vials (23.4 mg total used with maintenance dosing)
Insulin Syringes Per week: 1 syringe
  • 8 weeks: 8 syringes
  • 12 weeks: 12 syringes
  • 16 weeks: 16 syringes
  • 20 weeks: 20 syringes
Bacteriostatic Water Use ~3.0 mL per vial for reconstitution.
  • 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
  • 12 weeks (1 vial): 3 mL → 1 × 10 mL bottle
  • 16 weeks (1 vial): 3 mL → 1 × 10 mL bottle
  • 20 weeks (2 vials): 6 mL → 1 × 10 mL bottle Note: Use bacteriostatic water within 28 days after opening [9] .
Alcohol Swabs One for the vial stopper + one for the injection site each week.
  • Per week: 2 swabs
  • 8 weeks: 16 swabs
  • 12 weeks: 24 swabs
  • 16 weeks: 32 swabs

Protocol Overview

  • Goal: Support chronic weight management through GLP-1 receptor activation, leading to reduced appetite and improved metabolic parameters [1] .
  • Schedule: Weekly subcutaneous injections for 16–20+ weeks with gradual dose escalation.
  • Dose Range: 250 mcg (0.25 mg) to 2400 mcg (2.4 mg) weekly with stepwise titration every 4 weeks to improve tolerability.
  • Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements on standard insulin syringes.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F); use within 28 days; avoid repeated freeze–thaw cycles.

Dosing Protocol

  • Suggested weekly titration approach based on clinical approval and studies [1] [3] .
  • Weeks 1–4: 250 mcg (0.25 mg) once weekly to establish baseline tolerance.
  • Weeks 5–8: 500 mcg (0.5 mg) once weekly.
  • Weeks 9–12: 1000 mcg (1.0 mg) once weekly.
  • Weeks 13–16: 1700 mcg (1.7 mg) once weekly.
  • Weeks 17+ (Maintenance): 2400 mcg (2.4 mg) once weekly as target maintenance dose.
  • Frequency: Once per week (subcutaneous injection).

Storage Instructions

  • Proper storage preserves peptide quality and efficacy [7] [8] .
  • Lyophilized (powder): Store at −20 °C (−4 °F) in a cool, dry place protected from light.
  • For short-term storage (under a few months), 2–8 °C (35.6–46.4 °F) refrigeration is acceptable [7] .
  • Avoid humidity to prevent peptide degradation.
  • Reconstituted (solution): Refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze [8] .
  • Use within 28 days for maximum potency and safety; the benzyl alcohol in bacteriostatic water inhibits bacterial growth but solutions should still be discarded after approximately 4 weeks [9] .

04 · Good to know

Important Notes

  • This Semaglutide page is for educational research organization only.
  • Confirm route, dose, contraindications, monitoring, storage, and cycle decisions with qualified professional guidance.
  • Use sterile technique, rotate sites when applicable, and log missed doses, reactions, and inventory changes.

05 · How it works

How This Works

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control.

The extended half-life enables once-weekly subcutaneous dosing, which is the standard clinical approach [1] .

This educational protocol presents a gradual weekly titration from 0.25 mg up to a maintenance dose of 2.4 mg over 16+ weeks, using a practical dilution for precise insulin-syringe measurements.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • Semaglutide observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching